- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- News News
- Join Join
Conor King Devitt, The Oregonian
An effort to resolve differences in how Washington regulates medical and recreational marijuana will continue despite the death of legislation intended to accomplish that goal, a House Republican said.
Rep. Cary Condotta, R-East Wenatchee, said the state will convene a task force to figure out the issues of combining the medical marijuana system with the upcoming recreational marketplace. Senate Bill 5887, which would have added regulations and licensing to the state’s largely unregulated medical market, died in the House late Thursday due to a partisan revenue dispute that was unresolved at adjournment of the 60-day 2014 legislative session.
“We were hoping to be working on implementation at this point as opposed to working from square one again,” said Kari Boiter, the Washington coordinator for the national medical marijuana advocacy group Americans for Safe Access.
An August 2013 memorandum from the U.S. Justice Department said it would not fight marijuana legalization in states that create “strong and effective regulatory and enforcement systems that will address the threat those state laws could pose to public safety, public health and other law enforcement interests.”
Initiative 502, which Washington voters approved in November 2012, regulates sales of recreational marijuana much like sales of liquor. The state’s regulation of medical marijuana use, meanwhile, amounts to requiring a patient to obtain a doctor’s note.
Boiter said she is very concerned with what she considers a looming threat of federal intervention on a system the federal government has warned is untenable.
Boiter also said she is worried that medical marijuana patients might get cut off from the medicine they need at the local level. The city of Seattle has already informed medical dispensaries that without state licensing they will need to shut down by January of 2015.
Senate Bill 6542, which would have formed a task force to study how to create a cohesive recreational and medical system , also died in the House late Thursday as the Washington legislative session came to a close.
But Condotta said parties interested in action on the issue would convene a task force on their own.
Condotta seemed unconcerned with the risk of federal action, saying federal authorities have “have bigger fish to fry”.
The federal government has said the state of Washington will need to demonstrate it is working to improve its current medical marijuana regulatory system.